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E. VICENS-CALVET, J.!'I. VENORELL, !'I. ALBISU, N. POTAU, L. AUOI, !'I. GUSI~E. Children's Hospital Autonosous University. Barcelona. Spain. Tha dosage depandency on growth and saturity in growth horsona daficiency(GHO)treated with hussn growth hory sone(hGH). 28 GHO patients aged 3-10 yra. were treated with hGH (Roos-Kabi) during 1-4yrs. without pubertal interference. Dosages were 2eg in 01(N.'9) and 4sg in 02(N.9), 3 tieea/weak." patienta received treat.ent during 4 full yra.:6 in O,(rO,) and 5 in 02(r02).The 8esn Chronological Aga(CA),Bone Age(BA),Height(Ht)SOS·snd BA.SOS were coeparabla in both groupa st the onsat of treatsent. 1.-Tha avolution of height showad that in 02/r02 the ic reasa in SOS was significantly highar than in O,/rOl through the trsatsent.Tha cstch-up period was 3 yrs. in Dl/rOl and it was still praeent in 02/802 in tha 4th y2
. The biosynthetic hGH appears to be identical with regards to molecular weight and sequence with the exception of an N-terminal methionine. No contaminating proteins are present. Biological activity, determined by weight gain in hypophysectomized rats and sulfate incorporation into connective t issue appears to be identical to that of the pituitary hormone. Extensive toxicoligical studies suggest that the product should be safe for human use.
We conclude that the biosynthetic human growth hormone is comparable to the pitUitary hormone and this product once available should alleviate the shortage of hormone for the treatment of hypopituitary dwarfism.
A New Improved Method for Collecting Samples for Somatomedin C Determina ti on.
The c ur r e nt spec imen collection for the determination of Somatomedln C requires venipuncture, centrifugation, then serum or plasma separation followed by shipment to a laboratory performing the assay. Collection of capillary blood on specially prepared fi lter paper followed by air drying and mailing to the laboratory, removes all the steps of the traditional approach. Upon receipt by the laboratory, a l/S" disc is cut in the dot and the blood eluted by a buffer. The volume of blood in the l/S" dot is 0.15 microliters of plasma (Neonatal Screening programs) . The radioimmunoassay is then performed using second antibody separation technique following a sequential immunoassay using a rabbit anti-somatomedin C antibody and 1251 somatomedin C. The To study the effect of chronic administration of L-Dopa on growth 10 paira of rata, ..tchea by sibship and sex vere injected 5eg/kg Dopa. or sa11ne a.c. tvice daily. frca , to l' veeks of age. Pair feeding vu aaaured.
At l'veeka. after 2 days ort treat..nt the ani..l vere sacrificed.
Blood vaa collected for CHI RIA and the th:JlllWl. tbyroid. adrenala. uterua and gonada veighed.
Fe..le and ..Ie rats grev aignificantly better on L-Dopa:
, veeka 9 weeka
}Oa2 17=.5 180=9 :54=.7 206=15 37=.2 Dopa '1=2 17=.5 207=14 :56=.5 242=14 :59=.' Mal. Con.
:58=' 18=.2 272=6 :58=1.' :505=14 41=.8 Dopa 37=' 18=.' :505=12 40=.2 :542=1'+ '+'=.6 Serua CHI vu 8.'+4K1.'+ng/al in the Dopa and '+.6=0.9 in the control group.
All organa veighed tended to be huner in the Dopa group, though not aignificant~.
In concluaion: Chronic administration of L-Dopa produce a chronic stiaulation of CHI aecretion and enhancea growth in ..Ie and in feaale rate.
Evidence for the presence in human serum of an ultrafiltrable factor act ivat ing somatomed ins Human serum contains an ultrafiltrable factor (350 < M.W. < 700) which st imulates sulphation activities of native, or purified somatomed in A of either small or hig, molecular weight. The factor is heat s Differentiation of teratooarcino.. cells in oulture allova to stud7 certain aspecta of tbe early eebryogeneaia. Tbe adanylate oyolaae ayate. of oultured F9 cells is apecifically atimulated by oalcitonin. Differentiation into endodereal cella by treatment vitb retinoio aoid ie folloved by a loaa of caloitonin responaiveneaa and tbe appearanoe of parath7-roid borsone stiaulation of tbe cyclase ayate•• In addition radioiaaunologioal and biological aotive foraa of oaloitonin are aeoreted by F9 oella in the oulture medium. Along vitb differentiation vith retinoic acid a progreaaive deoreaae of calcitonin aeoretion ia obaerved I after 4 daya of treatsent no oaloitonin is any longer deteotable. But at tbia atage of differentiation a parath7roid boraone-like aubatenoe ia radioiaaunologioally and biologically deteotable. Theae apeoifio ohange. in borsonal aecretion and raceptivity oan be uaed a. aarker. of differentiation. Theae reaulta alao auggaat a poa-.ible role for Calcitonin and Parath7rotd horaona-like aotivitie. during the initial .tepa of embryogenesia.
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